Log in

CMA welcomes draft legislation that will deliver a world class regulatory regime

01 Sep 2017 12:40 PM | Anonymous

Complementary Medicines Australia (CMA) has today welcomed the exposure draft of the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 and reiterates its support of the government’s commitment to foster a regulatory environment that is supportive of innovation and competitiveness.

Read the full release here

Call us on 02 6260 4022 or fax 02 6260 4122
Follow us online
 

Address: PO Box 450 Mawson, ACT 2607 Australia

Powered by Wild Apricot Membership Software